EMEA-001724-PIP01-14
Key facts
| Active substance |
Levomilnacipran
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0128/2015
|
| PIP number |
EMEA-001724-PIP01-14
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of stroke
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Pierre Fabre Medicament
France
Tel. +33 149108081 |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|